Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models

Author： Kapitulnik Jaime   Pelkonen Olavi   Gundert-Remy Ursula   Dahl Svein G   Boobis Alan R  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.7, 2009-07, pp. : 867-887

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sample Size Computations for PK/PD Population Models

By Kang Dongwoo   Schwartz Janice   Verotta Davide  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 5-6, 2005-12 ,pp. : 685-701

Springer Publishing Company

Access to resources Recommend Favorite

Advances and Challenges in the Use of Nanoparticles to Optimize PK/PD Interactions of Combined Anti-Cancer Therapies

By  

Current Drug Metabolism, Vol. 15, Iss. 8, 2014-10 ,pp. : 818-828

Bentham Science Publishers

Access to resources Recommend Favorite

Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models

By  

Current Neuropharmacology, Vol. 15, Iss. 6, 2017-07 ,pp. : 815-830

Bentham Science Publishers

Access to resources Recommend Favorite

Translational PK-PD modeling in pain

By Yassen Ashraf  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 3, 2013-06 ,pp. : 401-418

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic-pharmacodynamic (PK-PD) modeling of cardiovascular effects of metoprolol in spontaneously hypertensive rats: a microdialysis study

By Höcht Christian   Di Verniero Carla   Opezzo Javier   Bramuglia Guillermo   Taira Carlos  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 373, Iss. 4, 2006-07 ,pp. : 310-318

Springer Publishing Company

Access to resources Recommend Favorite